Skip to Main Content

NEWS & RESOURCES

Bioscience

Positive Session for Bioscience Sector

The 2026 General Assembly session was one of the least contentious in recent memory for the biopharma sector. Bills calling for innovation-sapping price controls and unworkable programs…

Boehringer Partners on Connecticut Science Center STEM Lab

The Connecticut Science Center is home to exhibits, programs, and…

Costly Public Option Precursor Advances

The Connecticut General Assembly is exploring ways to address rising…

Content Type:

Bioscience

Legislature Reviews Drug Imports, Price Controls

Three important biopharma and medical device bills were the...

Bioscience

Rare Disease Day: Worth Your Attention

There are now many more “awareness” days than there...

Bioscience

Tax Proposals Promote, Discourage Bioscience Investment

Public hearings were held for several important biopharma bills...

Bioscience

bioscience research

Biopharma Bills: Tax Credits, Price Controls, Drug Imports

There are a record number of biopharma-related bills before...

Bioscience

Gov. Ned Lamont delivers his budget address Feb. 5, 2025.

State Budget: ‘Better Ways’ to Fund Governor’s Proposals

Gov. Ned Lamont proposed a $55.2 billion, two-year budget...

Bioscience

General Assembly Gets Early Start on Biopharma Legislation

Elected officials often remark that the issue raised most...

Bioscience

Healthcare Summit: Controlling the Cost Curve

CBIA’s 2025 Healthcare Summit: Controlling the Cost Curve provided...

Bioscience

HIV virus

Growing Private Sector Coalition Drives HIV Progress

CBIA has joined a growing coalition of private sector...

Bioscience

CBIA BizCast: ViiV’s Connecticut Success Story

Like its labs—tucked away at the far end of...

Stay Connected with CBIA News Digests

The latest news and information delivered directly to your inbox.